Gossamer Bio Seeks $230M IPO Amid Government Shutdown
Law360 (January 23, 2019, 9:20 PM EST) -- Biotechnology firm Gossamer Bio Inc. on Wednesday disclosed pricing details for a $230 million initial public offering, using an unconventional route that allows companies to go public without the usual green...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
